- Raised $690k funding round led by Cybele Holdings, Apr 2019
About
Pharmocann develops and produces Israeli medical cannabis on a farm located in the valley of Jezreel, the Galilee. The farm has hothouses for cannabis growth and propagation; a hothouse for the research and development of various cannabis strains; and other facilities required for the cultivation, harvesting, and production of medical cannabis.
The company is also a developer of medical marijuana cultivation centers and dispensaries. Pharmocann has established a strategic partnership with medical cannabis labs to produce standardized, validated, and GMP-manufactured medical cannabis products. Its line of products includes oil, ointments, tablets, inhalers, rectal and vaginal suppositories, and pre-rolled cigarettes of various types of THC/CBD strains.
Pharmocann’s latest developments include hydrogel products for the treatment of certain painful diseases, acute dermatological diseases, and inflammatory bowl diseases. Pharmocann serves more than 3,000 patients a month and yields about two tons of medical cannabis yearly.
Funding history · 1 round · $690K total
Q&A
- What is Pharmocann's primary business activity?
- Pharmocann specializes in medical cannabis cultivation and R&D, developing and producing Israeli medical cannabis on a farm in the Jezreel Valley, Galilee.
- When was Pharmocann founded?
- Pharmocann was founded in April 2008.
- What is Pharmocann's current employee count?
- Pharmocann has 1-10 employees.
- What types of medical cannabis products does Pharmocann offer?
- Pharmocann's product line includes oil, ointments, tablets, inhalers, rectal and vaginal suppositories, and pre-rolled cigarettes of various THC/CBD strains.
- What are Pharmocann's latest product developments?
- Pharmocann's latest developments include hydrogel products designed for the treatment of certain painful diseases, acute dermatological diseases, and inflammatory bowel diseases.
- How many patients does Pharmocann serve monthly and what is its annual yield?
- Pharmocann serves more than 3,000 patients a month and yields about two tons of medical cannabis yearly.
- What is Pharmocann's total funding raised to date?
- Pharmocann has raised a total of $690,000.
- When was Pharmocann's last funding round and who was the lead investor?
- Pharmocann's last funding round occurred in April 2019, with Cybele Holdings as the lead investor.
- What is Pharmocann's current market capitalization?
- Pharmocann's market capitalization is $863,314.
Sectors & technology
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | pharmocann.com/ |
|---|---|
| linkedin.com/company/18450262 | |
| facebook.com/pharmocann | |
| YouTube | youtube.com/channel/UC7Pti3NxrIprDie9JP2kVBg |
| instagram.com/pharmocann |
Identifiers & details
| Founded | 2008-4 |
|---|---|
| Employees (exact) | 8 |
| Market cap | $863K |
| Status reason | Public on TASE on Dec, 2018 |
Radar intelligence
Web history (Wayback)
| Domain | pharmocann.com |
|---|
Certificate / subdomain footprint
| Subdomains | 4 |
|---|